Treatment of a human breast cancer xenograft with an adenovirus vector containing an interferon gene results in rapid regression due to viral oncolysis and gene therapy.
about
p53 status does not determine outcome of E1B 55-kilodalton mutant adenovirus lytic infection.Replicative adenoviruses for cancer therapy.Oncolytic viruses as novel anticancer agents: turning one scourge against another.A gene therapy for cancer using intramuscular injection of plasmid DNA encoding interferon alpha.Replication-selective oncolytic viruses in the treatment of cancer.New approaches to rapidly control foot-and-mouth disease outbreaks.Adenovirus-mediated interferon alpha gene transfer induces regional direct cytotoxicity and possible systemic immunity against pancreatic cancerInterferon-beta gene therapy inhibits tumor formation and causes regression of established tumors in immune-deficient miceReprogrammed viruses as cancer therapeutics: targeted, armed and shielded.Phase I trial of recombinant adenovirus gene transfer in lung cancer. Longitudinal study of the immune responses to transgene and viral productsArmed replicating adenoviruses for cancer virotherapy.Engineering oncolytic viruses to exploit tumor specific defects in innate immune signaling pathways.Recent developments in oncolytic adenovirus-based immunotherapeutic agents for use against metastatic cancers.Treatment of melanoma with a serotype 5/3 chimeric oncolytic adenovirus coding for GM-CSF: Results in vitro, in rodents and in humans.Local interferon-alpha gene therapy elicits systemic immunity in a syngeneic pancreatic cancer model in hamster.Antitumor activity of IFIX, a novel interferon-inducible HIN-200 gene, in breast cancer.Genetic disruption of host interferon-gamma drastically enhances the metastasis of pancreatic adenocarcinoma through impaired expression of inducible nitric oxide synthase.
P2860
Q33785919-E7B1461D-E85B-42BB-AD95-081A0ABE83B1Q33963944-2D557136-B589-436D-9040-521DF96E5B04Q34074708-6480E6C3-014C-4894-A58F-1C0CA279EF56Q35000575-B14BAE64-A98E-4B86-8579-3133CE5B0227Q35912403-8AB6228D-4E48-44EB-AA65-127B488D387AQ35917287-8241A4EE-58E1-42A9-AAB1-B20A5DA87244Q36615168-B0C46B4D-2CD0-44BD-A2A5-89A88EFF92D9Q36735680-4243B49A-26BC-4724-B03D-A0118A5B117AQ37191007-4A14EDF8-EDCA-42EB-B1AD-A13888F5B4CCQ37374242-C45F936E-0F16-46E8-8AE1-1818EC069849Q37386616-494A8B67-05A6-4F15-9217-0C173CB0016BQ37564490-470B88D9-1403-4BF2-87CC-0E9E1104D7C1Q38073096-4D51CB8B-27B1-4042-8265-6957F3A3304EQ38893420-AE03E920-7517-448C-8F67-FA8972611EB7Q40181994-6E1A2AF5-4B9D-4170-8D08-96F593C17523Q44879958-10636CB4-B05B-4F06-85A2-1CB770B63F21Q52544473-A8D314C2-A2B2-4208-B5B8-03EAD469E75D
P2860
Treatment of a human breast cancer xenograft with an adenovirus vector containing an interferon gene results in rapid regression due to viral oncolysis and gene therapy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 1996
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Treatment of a human breast ca ...... al oncolysis and gene therapy.
@en
Treatment of a human breast ca ...... al oncolysis and gene therapy.
@nl
type
label
Treatment of a human breast ca ...... al oncolysis and gene therapy.
@en
Treatment of a human breast ca ...... al oncolysis and gene therapy.
@nl
prefLabel
Treatment of a human breast ca ...... al oncolysis and gene therapy.
@en
Treatment of a human breast ca ...... al oncolysis and gene therapy.
@nl
P2093
P2860
P921
P356
P1476
Treatment of a human breast ca ...... al oncolysis and gene therapy.
@en
P2093
P2860
P304
P356
10.1073/PNAS.93.9.4513
P407
P577
1996-04-01T00:00:00Z